Pharma

By Jonah Comstock November 17, 2017
Correction: An earlier version of this article was unclear about differences between Abilify MyCite and the Proteus Digital Medicine Platform.  Earlier this week, Proteus Digital Health and Otsuka Pharmaceuticals announced that Abilify MyCite, a new, sensor-enabled version of Otsuka’s drug for schizophrenia, had received FDA approval for mental health conditions including schizophrenia and...
By Laura Lovett November 16, 2017
Express Scripts members will now have access to Propeller’s FDA-cleared digital platform for respiratory health. Today, the two companies announced a partnership which they claim is the largest respiratory digital health deployment with a pharmacy benefit manager yet.  The Propeller system allows a patients to attach a sensor to their inhaler, which is synced to an app on the users smart phone....
By Mike Miliard November 14, 2017
The first drug in the US with a digital ingestion tracking system has been approved by the FDA. The pill, Abilify MyCite, is prescribed for treatment of schizophrenia, acute treatment of manic and mixed episodes associated with bipolar I disorder and as an add-on treatment for depression in adults. An ingestible sensor embedded in the pill is able to record that the medication was taken – sending...
By Dave Muoio November 13, 2017
Humana and Johnson & Johnson have each announced a new challenge competition for digital health students and entrepreneurs. The former seeks novel approaches to easy and understandable EHR management with a focus on Medicare-compatibility, and will award up to $10,000. The latter is offering up to $50,000 for new skin care strategies potentially incorporating tracking devices, adherence...
By Dave Muoio November 9, 2017
Pfizer and the Friends of Haemophilia Society have launched an app game specifically designed to help boys aged four years and older learn about and manage their hemophilia.  Released in Qatar, “HemoHeroes” tasks players with guiding their ‘hero’ through different everyday scenarios, such as exercising, cooking, and bathing. While each of these are designed to be a fun challenge, they also focus...
By Dave Muoio November 8, 2017
Tel-Aviv, Israel-based Vaica, a producer of cloud-based medication adherence products, has announced a new in-home device to help patients stick to their treatments. The Capsuled device stores medications, and includes reminders, informational materials, and other features designed to better enable patients’ daily medication routines. "The Capsuled is a unique patient adherence product targeted...
By Dave Muoio November 2, 2017
North Carolina-based Pneuma Respiratory has announced a fully digital soft mist inhaler device. The inhaler can deliver several different types of medicines directly to the lungs, and by syncing with a mobile app can be used to verify dose delivery in real-time. “What we’ve done is created the first electronically breath-actuated inhaler,” James Bauler, VP of business development at Pneuma...
About the Authors: Bradley Merrill Thompson is a member of the firm at Epstein Becker & Green, P.C. There, he counsels medical device, drug, and combination product companies on a wide range of FDA regulatory issues.  Chris Bergstrom is a digital health leader, for The Boston Consulting Group (BCG). At BCG, he directs digital health initiatives across large payer, provider, med tech, and bio/...
By Dave Muoio October 25, 2017
A newly announced study backed by Takeda Pharmaceuticals, Lundbeck US, and Advocate Health Care will explore the effectiveness of a mobile app designed to improve engagement between patients with major depressive disorder (MDD) and their providers. The investigation will use the Advocate Pathway App to capture the start of or any adjustments to a patient’s antidepressant therapy. Through a...
By Jonah Comstock October 20, 2017
Pharma companies were fairly active in digital health in the third quarter of 2017, especially in the areas of diabetes and respiratory disease. Read on for a round-up of notable events. Diabetes management Abbott Diabetes Care had a big quarter for its Freestyle Libre system, both in the United States and abroad. First, in July, Abbott and Bigfoot Biomedical entered into an agreement to develop...